Chang-Jin Kim Selected Research

Chang-Jin Kim Research Topics

Disease

14	Neoplasms (Cancer) 03/2022 - 01/2002
8	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 06/2011
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2011 - 05/2010
4	Carcinogenesis 03/2022 - 05/2010
3	Carcinoma (Carcinomatosis) 06/2011 - 11/2007
2	Lung Neoplasms (Lung Cancer) 02/2016 - 01/2016
2	Persistent Infection 11/2012 - 04/2012
1	Adenocarcinoma of Lung 07/2019
1	Neoplasm Metastasis (Metastasis) 02/2016
1	Adenocarcinoma 01/2016
1	Infections 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Meningitis 01/2013
1	Papillary Thyroid Cancer 02/2012
1	Hypoxia (Hypoxemia) 11/2007
1	Colonic Neoplasms (Colon Cancer) 11/2007
1	Corneal Neovascularization 02/2007
1	Seizures (Absence Seizure) 04/2005

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 08/2020 - 06/2010
3	Small Interfering RNA (siRNA)IBA 10/2020 - 07/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2005
3	AgarIBA 12/2017 - 03/2011
2	VimentinIBA 07/2019 - 05/2011
2	Anti-Infective Agents (Microbicides)IBA 11/2012 - 04/2012
2	Messenger RNA (mRNA)IBA 06/2011 - 05/2010
2	Antineoplastic Agents (Antineoplastics)IBA 11/2007 - 03/2005
2	Glucose (Dextrose)FDA LinkGeneric 11/2007 - 03/2005
1	Tumor Biomarkers (Tumor Markers)IBA 03/2022
1	Biological ProductsIBA 03/2022
1	Polyamine OxidaseIBA 03/2022
1	Histone ChaperonesIBA 10/2020
1	MicroRNAs (MicroRNA)IBA 08/2020
1	streptimidoneIBA 01/2020
1	leu-13 antigenIBA 07/2019
1	CateninsIBA 07/2019
1	Cadherins (E-Cadherin)IBA 07/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	alpha-DefensinsIBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 06/2018
1	Protein Kinases (Protein Kinase)IBA 06/2018
1	Karyopherins (Importin)IBA 12/2017
1	Angiopoietin-2IBA 07/2017
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2016
1	ErbB Receptors (EGF Receptor)IBA 02/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2016
1	Polymyxins (Polymyxin)IBA 01/2016
1	NetropsinIBA 01/2016
1	Peptide Nucleic AcidsIBA 02/2012
1	SurvivinIBA 06/2011
1	MethyltransferasesIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2011
1	A-Form DNA (A-DNA)IBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	hydrogen sulfite (bisulfite)IBA 05/2010
1	trioctyl phosphine oxide (TOPO)IBA 11/2007
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2007
1	Plicamycin FDA Link 11/2007
1	Etoposide (VP 16)FDA LinkGeneric 11/2007
1	embellistatinIBA 02/2007
1	Glutamic Acid (Glutamate)FDA Link 04/2005
1	Kainic Acid (Kainate)IBA 04/2005
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2005
1	5-demethylovalicinIBA 01/2002
1	methionine aminopeptidase 2IBA 01/2002

Therapy/Procedure

1	Adjuvant Chemotherapy 12/2017
1	Therapeutics 01/2016
1	Aftercare (After-Treatment) 01/2013